Trialect

+ More Filters

Reset Filters

Title

Funding Organization

Funding Type

Eligible Country

Deadline

Other (Select all that apply)

Show Expired Programs

Show Verified Programs

Verified

Damon Runyon Fellowship Award

Damon Runyon Cancer Research Foundation

The Foundation encourages all theoretical and experimental research relevant to the study of cancer and the search for cancer causes, mechanisms, therapies and prevention including molecular approaches to cancer prevention for inherited cancers.

Candidates must apply for the fellowship under the guidance of a Sponsor—a scientist (tenured, tenure-track or equivalent position) capable of providing mentorship to the Fellow. In addition to aiding in the planning, execution and supervision of the proposed research, the Sponsor’s role is to foster the development of the Fellow’s overall knowledge, technical and analytical skills, and capacity for scientific inquiry. The Sponsor is also expected to assist the Fellow in attaining their career goals.

Awards are made to institutions for the support of the Fellow under direct supervision of the Sponsor. Candidates who have already accepted a postdoctoral research fellowship award are not eligible.

Specialties

Cancer

Oncology

Eligibility Requirements

Applicants must have completed one or more of the following degrees or its equivalent: MD, PhD, MD/PhD, DDS, DVM, DO. The applicant must include a copy of their diploma to confirm date of conferral. (If an applicant has not yet received their PhD diploma but has successfully completed all PhD requirements, including PhD defense, they may submit a letter from the graduate school explicitly stating such, with the date of the successful PhD defense and date of degree conferral.)

Level 1: Basic and physician-scientists must have received their degrees no more than 18 months prior to the application deadline date. Applicants must not have been in their Sponsors' labs for more than one year prior to the application deadline date and are expected to devote 100% of their time to Damon Runyon-supported research activities.

Level 2: Physician-scientist applicants (MD, MD/PhD, DDS, DVM, DO or the equivalent) must have completed their residencies and clinical training, must be board eligible in the United States at the start date of the Damon Runyon Fellowship, and be able to devote at least 80% of their time to Damon Runyon-supported research activities. Applicants may apply at any time prior to their initial assistant professorship appointment (or equivalent); postdoctoral fellows, clinical fellows and clinical instructors are eligible to apply. Candidates holding or awarded NIH K awards at the time of application are not eligible to apply. Candidates holding institutional K12 awards may apply, but must turn-back K12 funding if they are awarded a Damon Runyon Fellowship.

Sponsor Details

Sponsor Institute/Organizations: Damon Runyon Cancer Research Foundation

Sponsor Type: Corporate/Non-Profit

Address: One Exchange Plaza 55 Broadway, Suite 302 New York, NY 10006

Legal & Affiliation Disclaimer

Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.

Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.

Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.

Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.

Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.

Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.

Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.

View Funding Opportunity